about
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.Electrophysiological Adverse Effects of Direct Acting Antivirals in Patients With Chronic Hepatitis C.Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon.Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progressionImpact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis.Clinical significance of hyperhomocysteinemia in infective endocarditis: A case-control study.Management of Gram-negative and fungal endocarditis.Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance.Current trends in the management of cardiac implantable electronic device (CIED) infections.Combination therapy in severe Acinetobacter baumannii infections: an update on the evidence to date.The role of hemostasis in infective endocarditis.Recipient-born bloodstream infection due to extensively drug-resistant Acinetobacter baumannii after emergency heart transplant: report of a case and review of the literature.International experts' practice in the antibiotic therapy of infective endocarditis is not following the guidelines.Viability of pegIFNα-RBV for CHC in the direct acting antiviral era: a practical algorithm between efficacy and cost containment.Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis.Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management.Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis.Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients.Effect of the immunosuppressive regimen on the incidence of cytomegalovirus infection in 378 heart transplant recipients: A single centre, prospective cohort study.Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii.Prevalence and significance of two major inherited thrombophilias in infective endocarditis.Differential antiviral effects of pegylated interferon-α2a and pegylated interferon-α2b in chronic hepatitis C.Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact.Can we go for a shorter treatment course in chronic hepatitis C? More inspiring cases.Infective endocarditis due to multidrug resistant gram-negative bacilli: single centre experience over 5 years.In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment.Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-alpha preparations.Management of immunosuppression and antiviral treatment before and after heart transplant for HIV-associated dilated cardiomyopathy.A European first: successful heart transplant in a human immunodeficiency virus-positive recipient.Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices.Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study.Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis.The current role of glycopeptides in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in not neutropenic adults: the viewpoint of a group of Italian experts.
P50
Q30276114-43768B80-7C47-48F1-BA91-866F1F21A6AEQ33168181-E25C7414-2423-48D2-8815-C8B6EBF680DAQ33385632-60CBECE6-3083-4A39-868B-E0965C1F03ABQ34263370-B07D35F1-45E7-4346-9C3D-69D6948967A4Q35197262-AA26007E-A7EB-4B04-9022-E2ACCF2A8527Q37270240-DDAB1DE7-2365-47AD-ADA9-3AA0D6DA5274Q37335865-09E1A3B7-299D-4646-B9B1-263F4B530DA6Q37605879-194D120B-C960-4152-BD8C-7AC4E3779D0BQ37815680-D4486F3E-6CCE-4F23-8FE7-2D35CEE49CEDQ37869910-1BD277DF-36B4-4BD4-AC50-31C963A723CFQ38022551-252E72C2-8FA9-435F-897E-79A9F36141FBQ38232199-6FDF9BBE-C9A5-495E-BA69-D15B41DFCA24Q38250442-0655D214-8D3F-459C-82D6-CDC4E9F26B27Q38398492-F4CF8AF5-F531-44C4-A6B9-337855007B11Q38890816-4B978B13-771D-4E96-80CA-F22FF9F55644Q39649542-782078DA-0184-411D-8564-5D65C37BB47AQ40048471-CA1CA5CB-045F-4D51-BE66-1620B38FB7EAQ40093594-3AA4AA84-CB9C-4822-B729-1149AD4ABD78Q40533079-B62A73CD-E08A-4798-8E21-078F150A5376Q40568517-6D1007C3-5B66-405A-A9C9-6618ECB54852Q40586613-B0A0A636-6A61-4A0F-ACA2-578962C916CCQ40646657-7BA3AFAD-7A85-4A0D-930E-9DD3ACDFDCE5Q40751072-40AB1DDB-18FA-47BC-92BF-64514F5BCC13Q41163755-D3AA38F5-2BC2-41D2-9548-8F8FBBCADF9CQ41348499-795EAFAF-D496-4B4C-B15A-EB6BB3E8A76EQ41357906-30FA8514-55D1-4F07-BA4F-8B947B613762Q41687110-327017B1-C489-4F4B-942A-E16DDEA26FF6Q41927306-1AD03AF2-251E-47F2-A014-57C0C6E8D201Q41996616-5123014D-2A97-45D1-AB03-D16DF6817BEFQ42210732-1752BC26-3941-460B-B77F-57CD6ABA103BQ42254947-7DAF6E33-DA5E-4A0F-8A4D-378DC7581BFDQ42978459-0D7F5A4F-8642-4B81-A327-ECA4CE16B5F2Q42989256-64ADA6C9-4755-4BB7-A75F-529F2F984F93Q43049341-323DEB67-8858-4918-BF33-57FB8A759C6FQ43584691-C320EB08-DC78-4575-9BED-CDD5B1AF58DEQ43656758-2AAE0D61-75AF-429C-A803-11374CB8A39EQ43917796-8F310E06-AC5B-4C7D-8F6E-099B4F283248Q46291398-7179ACD9-ABE4-4BE4-818D-1983CFD159A0Q47605089-5FB1FC18-85B2-4559-85E7-E7C2570005B3Q48143654-37EE11C0-9F02-45AB-A941-E5058A01C437
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
E Durante-Mangoni
@ast
E Durante-Mangoni
@en
E Durante-Mangoni
@es
E Durante-Mangoni
@nl
type
label
E Durante-Mangoni
@ast
E Durante-Mangoni
@en
E Durante-Mangoni
@es
E Durante-Mangoni
@nl
prefLabel
E Durante-Mangoni
@ast
E Durante-Mangoni
@en
E Durante-Mangoni
@es
E Durante-Mangoni
@nl
P106
P31
P496
0000-0002-5381-3537